Content available only in Spanish.
Preeclampsia and kidney disease in a transplant center: analysis and MINERVA strategy
Preeclampsia and kidney disease in a transplant center: analysis and MINERVA strategy
Ana L. Noriega-Salas 1 
, Neftalí A. Ángeles-Ramos 1 , Melani I. López-Aguilar 1 , Catalina D.R. García-Ramírez 1 , David J. Ángeles-Ramos 1 , Melina Y. Aguirrez-Andraca 1
1 Unidad de Trasplantes, Hospital de Especialidades, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Ciudad de México, México
*Correspondence: Ana L. Noriega-Salas. Email: noriega_lorena@hotmail.com
Abstract
Objective: To determine the prevalence of a history of preeclampsia as a cause of chronic kidney disease in women post-renal transplant at a study center. Material and methods: A retrospective, descriptive, and longitudinal study conducted through the review of clinical records of women diagnosed with CKD who received a renal transplant between January 2017 and September 2024 at the Renal Transplant Unit of the Dr. Antonio Fraga Mouret Specialty Hospital. A history of preeclampsia was identified. Clinical, demographic, and post-transplantation evolving variables were analyzed. Results: Of 730 renal transplants, 35 patients (4.79%) had a history of preeclampsia. The mean age was 34.8 ± 7.4 years. The predominant replacement therapy was hemodialysis (45.7%). The graft loss rate at six months was 8.3%. Regarding the donors, 69.4% were living, with a mean age of 39.8 ± 15.1 years. Conclusions: These findings underscore the importance of considering obstetric and gynecological history in nephrological evaluations and implementing follow-up strategies at the primary care level for patients with a history of preeclampsia.
Keywords: Preeclampsia. MINERVA. Transplant.
